n.adeyemi
Submits third-party assay reports on material purchased directly. Based in Basel.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.32%
n=6
Suppliers covered
6
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042072 | SS-31 (Elamipretide) | TFC | TFC-2604-Y7472 | VendorInvestigate | 2026-Q3 | 97.88 | 3.47 | 89.5 | Buyer-sourced | 2 | FAIL |
| AX-2026-041685 | CJC-1295 (no DAC) | QSC | QSC-2606-V8637 | Medutest | 2026-Q3 | 99.93 | 3.62 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042693 | Retatrutide | GGPeps | GGPE-2512-D9394 | Nordanalyt | 2026-Q2 | 98.76 | 4.16 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020833 | SS-31 (Elamipretide) | SGN | SGN-2507-U1475 | Janoshik | 2025-Q4 | 96.77 | 4.18 | 103.7 | Buyer-sourced | 0 | FAIL |
| AX-2025-020570 | Vilon | SSA | SSA-2508-B6325 | Nordanalyt | 2025-Q3 | 99.13 | 6.08 | 94.9 | Supplier-supplied | 0 | FAIL |
| AX-2024-005441 | Retatrutide | WXT | WXT-2407-A5417 | Janoshik | 2024-Q4 | 97.28 | 4.07 | — | Buyer-sourced | 3 | MARGINAL |